Biotalys NV Aktie

3,59 EUR +0,14 EUR +4,06 %

10:48:45

STU

3,59 EUR +0,12 EUR +3,46 %

13.03.2025

EBR

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.130,02 Mio. EUR

Div. Rendite0,00%

WKNA3CS50

ISINBE0974386188

Biotalys NV Aktien News

Sortieren:Datum Meistgelesen

11.03.25GlobeNewswireBiotalys Achieves Strong Results in Field Trials with Second Biofungicide

27.01.25GlobeNewswireInformation on the total number of voting rights and shares

14.01.25GlobeNewswireBiotalys Provides Regulatory Review Update on EVOCA

WerbungBiotalys NV-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

23.10.24GlobeNewswirePublication of transparency notifications

17.10.24GlobeNewswireBiotalys Appoints Kamal El Mernissi as Chief Business Development Officer

16.10.24GlobeNewswireBiotalys announces Closing of Private Placement

14.10.24GlobeNewswireBiotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors

01.10.24GlobeNewswireBiotalys Expands R&D Pipeline with New Biofungicide Program

17.09.24GlobeNewswireBiotalys Granted Patents for EVOCA in Both Europe and the United States

02.09.24GlobeNewswireBiotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

22.08.24GlobeNewswireBiotalys Reports Half-Year 2024 Financial Results and Business Highlights

21.08.24GlobeNewswireBiotalys Named Sustainable Crop Protection Company of the Year

05.08.24GlobeNewswireBiotalys Notice of Half Year 2024 Results and Business Highlights

02.05.24GlobeNewswireBiotalys Starts Field Trials for Second Biofungicide

30.04.24GlobeNewswireBiotalys Appoints Laura J. Meyer to Board of Directors

23.04.24GlobeNewswireResults of the Ordinary and Extraordinary Shareholders’ Meeting

29.03.24GlobeNewswireResults of the Special Shareholders’ Meeting

20.03.24GlobeNewswireInvitation to the ordinary general shareholders meeting and an extraordinary shareholders meeting

18.03.24GlobeNewswireBiotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG

26.02.24GlobeNewswireInvitation to a Special Shareholders’ Meeting

22.02.24GlobeNewswireBiotalys Reports Full-Year 2023 Financial Results and Business Highlights

08.02.24GlobeNewswireBiotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S.

31.01.24GlobeNewswireInformation on the total number of voting rights and shares

22.01.24GlobeNewswireBiotalys Notice of Full Year 2023 Results and Business Highlights

19.12.23GlobeNewswireBiotalys Announces Results of Independent Field Trials in the U.S.

29.11.23GlobeNewswireBiotalys Provides Company Update

05.10.23GlobeNewswireKevin Helash commences role as Chief Executive Officer of Biotalys

02.10.23GlobeNewswireBiotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

26.09.23GlobeNewswireBiotalys announces participation at upcoming scientific, industry and investor events

23.08.23GlobeNewswireBiotalys Reports Half-Year 2023 Financial Results and Business Highlights

20.07.23GlobeNewswireInvitation to a Special Shareholders’ Meeting

05.07.23GlobeNewswirePublication of transparency notification

12.06.23GlobeNewswireBiotalys announces closing of private placement

07.06.23GlobeNewswireBiotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million

31.05.23GlobeNewswireBiotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials

25.04.23GlobeNewswireResults of the Annual and Extraordinary Shareholders’ Meeting

24.04.23GlobeNewswireSyngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture

24.03.23GlobeNewswireInvitation to the Annual and an Extraordinary Shareholders Meeting

14.03.23GlobeNewswireBiotalys announces Chief Financial Officer succession plan

28.02.23GlobeNewswireBiotalys Reports Full-Year 2022 Financial Results and Business Highlights

Biotalys NV News

Biotalys NV News: auf dieser Seite finden Sie alle Biotalys NV News und Nachrichten zur Biotalys NV Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Biotalys NV News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Biotalys NV News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.